Recent Finacing
Recent Raise
ImmunoSolv Limited develops Dead-Cert dead-cell removal reagents and a magnetic Dead-Cert Nanoparticles separator, offers GBC contract research, and builds apoptosis-detection and antibody-engineering technologies for therapeutics.
Recent Investors
Total Raised
Funding round
Investors